User menu

Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.

Bibliographic reference Dohrn, Maike F ; Röcken, Christoph ; De Bleecker, Jan L ; Martin, Jean-Jacques ; Vorgerd, Matthias ; et. al. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.. In: Journal of Neurology : official journal of the European Neurological Society, Vol. 260, no.12, p. 3093-3108 (2013)
Permanent URL http://hdl.handle.net/2078.1/150742
  1. ANDRADE CORINO, A PECULIAR FORM OF PERIPHERAL NEUROPATHY : FAMILIAR ATYPICAL GENERALIZED AMYLOIDOSIS WITH SPECIAL INVOLVEMENT OF THE PERIPHERAL NERVES, 10.1093/brain/75.3.408
  2. Schonland S. O., Hegenbart U., Bochtler T., Mangatter A., Hansberg M., Ho A. D., Lohse P., Rocken C., Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients, 10.1182/blood-2011-06-358507
  3. Sommer C., Schr�der J. M., Amyloid neuropathy: immunocytochemical localization of intra- and extracellular immunoglobulin light chains, 10.1007/bf00294378
  4. Linke Reinhold P., On Typing Amyloidosis Using Immunohistochemistry. Detailled Illustrations, Review and a Note on Mass Spectrometry, 10.1016/j.proghi.2012.03.001
  5. Liz MA, Mar FM, Franquinho F, Sousa MM (2010) Aboard transthyretin: from transport to cleavage. IUBMB Life 62:429–435
  6. Costa P. P., Figueira A. S., Bravo F. R., Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy., 10.1073/pnas.75.9.4499
  7. Cardoso I, Goldsbury C.S, Müller S.A, Olivieri V, Wirtz S, Damas A.M, Aebi U, Saraiva M.J, Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils 1 1Edited by M. Moody, 10.1006/jmbi.2002.5441
  8. Quintas Alexandre, Vaz Daniela C., Cardoso Isabel, Saraiva Maria João M., Brito Rui M. M., Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants, 10.1074/jbc.m101024200
  9. Planté-Bordeneuve Violaine, Said Gerard, Familial amyloid polyneuropathy, 10.1016/s1474-4422(11)70246-0
  10. Conceição Isabel, De Carvalho Mamede, Clinical variability in type I familial amyloid polyneuropathy (Val30Met): Comparison between late- and early-onset cases in Portugal, 10.1002/mus.20644
  11. Hund E., Linke R. P., Willig F., Grau A., Transthyretin-associated neuropathic amyloidosis: Pathogenesis and treatment, 10.1212/wnl.56.4.431
  12. Westermark P., Sletten K., Johansson B., Cornwell G. G., Fibril in senile systemic amyloidosis is derived from normal transthyretin., 10.1073/pnas.87.7.2843
  13. Bulawa C. E., Connelly S., DeVit M., Wang L., Weigel C., Fleming J. A., Packman J., Powers E. T., Wiseman R. L., Foss T. R., Wilson I. A., Kelly J. W., Labaudiniere R., Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade, 10.1073/pnas.1121005109
  14. Chambers James K., Kuribayashi Hiroyuki, Ikeda Shu-Ichi, Une Yumi, Distribution of neprilysin and deposit patterns of Aβ subtypes in the brains of aged squirrel monkeys (Saimiri sciureus), 10.3109/13506129.2010.483119
  15. Said Gerard, Grippon Seden, Kirkpatrick Peter, Tafamidis, 10.1038/nrd3675
  16. Holmgren Gösta, Steen Lars, Ekstedt Jan, Groth Carl-Gustav, Ericzon B.-G., Eriksson Siv, Andersen Oluf, Karlberg Ingvar, Nordén Gunnela, Nakazato Masamitsu, Hawkins Philip, Richardson Suzanne, Pepys Mark, Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30), 10.1111/j.1399-0004.1991.tb03085.x
  17. Holmgren G, Steen L, Suhr O, Ericzon B.-G, Groth C.-G, Andersen O, Wallin B.G, Seymour A, Richardson S, Hawkins P.N, Pepys M.B, Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis, 10.1016/0140-6736(93)93127-m
  18. Dubowitz V, Sewry C (2007) Histological and histochemical stains and reactions. Muscle biopsy a practical approach. Elsevier, Philadelphia, pp 3–39
  19. Schr�der J. M., Hoheneck M., Weis J., Deist H., Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy, 10.1007/bf00313906
  20. Weis Joachim, Brandner Sebastian, Lammens Martin, Sommer Claudia, Vallat Jean-Michel, Processing of nerve biopsies: A practical guide for neuropathologists, 10.5414/np300468
  21. Benson Merrill D., Kincaid John C., The molecular biology and clinical features of amyloid neuropathy, 10.1002/mus.20821
  22. Jacobson Daniel R., Pastore Raymond D., Yaghoubian Robert, Kane Immaculata, Gallo Gloria, Buck Francis S., Buxbaum Joel N., Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans, 10.1056/nejm199702133360703
  23. Mathis Stephane, Magy Laurent, Diallo Laho, Boukhris Sami, Vallat Jean-Michel, Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy, 10.1002/mus.22229
  24. Cappellari Manuel, Cavallaro Tiziana, Ferrarini Moreno, Cabrini Ilaria, Taioli Federica, Ferrari Sergio, Merlini Giampaolo, Obici Laura, Briani Chiara, Fabrizi Gian Maria, Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients, 10.1111/j.1529-8027.2011.00331.x
  25. Palaninathan Satheesh K., Mohamedmohaideen Nilofar N., Snee William C., Kelly Jeffery W., Sacchettini James C., Structural Insight into pH-Induced Conformational Changes within the Native Human Transthyretin Tetramer, 10.1016/j.jmb.2008.07.029
  26. Wilkinson-White Lorna E., Easterbrook-Smith Simon B., Characterization of the Binding of Cu(II) and Zn(II) to Transthyretin:  Effects on Amyloid Formation†, 10.1021/bi700607z
  27. Zhang Qinghai, Kelly Jeffery W., Cys-10 Mixed Disulfide Modifications Exacerbate Transthyretin Familial Variant Amyloidogenicity:  A Likely Explanation for Variable Clinical Expression of Amyloidosis and the Lack of Pathology in C10S/V30M Transgenic Mice?†, 10.1021/bi050378f
  28. Almeida M.R., Alves I.L., Terazaki H., Ando Y., Saraiva M.J., Comparative Studies of Two Transthyretin Variants with Protective Effects on Familial Amyloidotic Polyneuropathy: TTR R104H and TTR T119M, 10.1006/bbrc.2000.2554
  29. Hammarstrom P., Jiang X., Hurshman A. R., Powers E. T., Kelly J. W., Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity, 10.1073/pnas.202495199
  30. Hurshman Babbes Amy R., Powers Evan T., Kelly Jeffery W., Quantification of the Thermodynamically Linked Quaternary and Tertiary Structural Stabilities of Transthyretin and Its Disease-Associated Variants: The Relationship between Stability and Amyloidosis†, 10.1021/bi800636q
  31. Soares M. L., Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease, 10.1093/hmg/ddi051
  32. Sousa MM, Du Y, Fernandes R, Guimarães A, Stern D, Saraiva MJ (2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 21:7576–7586
  33. Sousa Mónica Mendes, Saraiva Maria João, Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling, 10.1016/j.pneurobio.2003.11.002
  34. Koike Haruki, Type I (Transthyretin Met30) Familial Amyloid Polyneuropathy in Japan : Early- vs Late-Onset Form, 10.1001/archneur.59.11.1771
  35. Koike Haruki, Sobue Gen, Late-onset familial amyloid polyneuropathy in Japan, 10.3109/13506129.2012.674580
  36. Koike H., Misu K., Sugiura M., Iijima M., Mori K., Yamamoto M., Hattori N., Mukai E., Ando Y., Ikeda S., Sobue G., Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy, 10.1212/01.wnl.0000132966.36437.12
  37. Koike Haruki, Ando Yukio, Ueda Mitsuharu, Kawagashira Yuichi, Iijima Masahiro, Fujitake Junko, Hayashi Michiyuki, Yamamoto Masahiko, Mukai Eiichiro, Nakamura Tomohiko, Katsuno Masahisa, Hattori Naoki, Sobue Gen, Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy, 10.1016/j.jns.2009.07.028
  38. Monteiro F. A., Sousa M. M., Cardoso I., Amaral J. Barbas, Guimaraes A., Saraiva M. J., Activation of ERK1/2 MAP kinases in Familial Amyloidotic Polyneuropathy, 10.1111/j.1471-4159.2006.03716.x
  39. Monteiro Filipe Almeida, Cardoso Isabel, Sousa Mónica Mendes, Saraiva Maria João, In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE), 10.1016/j.febslet.2006.05.020
  40. Sousa Mónica Mendes, Yan Shi Du, Stern David, Saraiva Maria João, Interaction of the Receptor for Advanced Glycation End Products (RAGE) with Transthyretin Triggers Nuclear Transcription Factor kB (NF-kB) Activation, 10.1038/labinvest.3780116
  41. Sousa Mónica Mendes, Fernandes Rui, Palha Joana Almeida, Taboada Ana, Vieira Paulo, Saraiva Maria João, Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro, 10.1016/s0002-9440(10)64469-0
  42. Stern David, Du Yan Shi, Fang Yan Shi, Marie Schmidt Ann, Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings, 10.1016/s0169-409x(02)00160-6
  43. Non-senile wild-type transthyretin systemic amyloidosis presenting as bilateral carpal tunnel syndrome, 10.1111/j.1529-8027.2008.00170.x
  44. Comenzo R. L., Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins, 10.1182/blood-2005-10-4148
  45. Suhr Ole B., Ericzon Bo-Göran, Selection of hereditary transthyretin amyloid patients for liver transplantation: the Swedish experience, 10.3109/13506129.2012.673139
  46. Koike H., Kawagashira Y., Iijima M., Yamamoto M., Hattori N., Tanaka F., Hirayama M., Ando Y., Ikeda S.-i., Sobue G., Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci, 10.1007/s00415-008-0962-z